Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: NA: NA
Control Intervention1: NA: NA
Sponsors
Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: All adult patients above 18 years posted for elective breast onco-surgery with curative intent, in TMH or ACTREC for a duration of six months, will be screened and included in the analysis
Exclusion criteria
Exclusion criteria: Emergency breast surgery Pediatric patients below 18 years Patients for palliative breast surgery Patients with metastatic breast cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 To find the incidence of surgical site infection (SSI) rate after breast onco-surgery 2 To find a threshold HbA1c level and FBS on day of surgery in diabetic patients, to predict an increase in 90-day surgical site infections (SSI) Timepoint: 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To assess association of above investigations with the type of breast surgery and type of SSI. 2 To ascertain the factors which could have affected the SSI 3 To understand if there is any need to change current antibiotic policies in the subset of patients with diabetes, obesity, type 2 oncoplasties and other patients with high riskaccording to multivariate analysis Timepoint: 6 month after enrolment | — |
Countries
India
Contacts
Public ContactDr Shalaka Joshi
Tata Memorial Centre
Outcome results
None listed